Methylprednisolone Augments IV Immune Globulin Response in Children With ITP
Intravenous immune globulin (IVIG) plus intravenous methylprednisolone (IVMP) confers a more rapid increase in platelet counts in children with immune thrombocytopenia (ITP), compared with...
Tisagenlecleucel Improves Patient-Reported Quality of Life in Relapsed/Refractory DLBCL
Treatment with tisagenlecleucel was associated with clinically meaningful improvements in health-related quality of life (QoL) over 18 months in patients with diffuse large B-cell...
High Bleeding Events in SCD Warrant Consideration of In-Hospital Ulcer Prophylaxis
By the time they reach age 40, 21% of patients with sickle cell disease (SCD) will have experienced a bleeding event, with most events...
Men Have More Published Research Than Women, Regardless of Caregiving Responsibilities
Previous research has shown that hematologists who participated in the American Society of Hematology’s (ASH’s) Clinical Research Training Institute (CRTI) experienced greater levels of...
Can Dasatinib Overcome the Negative Effects of KIT Mutations in Core Binding Factor AML?
A chemotherapy regimen of cytarabine and daunorubicin plus dasatinib was well tolerated in patients with previously untreated core binding factor acute myeloid leukemia (CBF-AML)...
Metabolic Syndrome Predicts Risk of Recurrent VTE in Patients With Newly Diagnosed DVT
Patients with newly diagnosed deep vein thrombosis (DVT) who have components of metabolic syndrome – hypertension, hyperlipidemia, diabetes mellitus, or obesity – have a...
The MAGIC Marker: Measurements of Two Serum Biomarkers Predict GVHD Treatment Response
Measuring damage to crypts in the gastrointestinal tract during graft-versus-host disease (GVHD) via the Mount Sinai Acute GVHD International Consortium (MAGIC) algorithm probability (MAP)...
Early Peripheral Blast Cell Clearance Predicts Response to Induction Chemotherapy in Acute Myeloid Leukemia
Early peripheral blast cell clearance (PBC) assessed by leukocyte differential is well established as a predictor of leukemia induction outcome, but measuring PBC by...
Defining the Goals of Venetoclax Treatment in Relapsed/Refractory CLL
Achieving undetectable measurable residual disease (MRD) predicts a better clinical outcome in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) who are treated with venetoclax,...
Shifting From Eligibility to Optimization of Transplant in Older Adults With Hematologic Malignancies
In an article published in Blood Advances, researchers from the University of Chicago reported efforts to optimize outcomes after hematopoietic cell transplantation (HCT) in...
Current Issue
July 2020 Volume 6 Issue 8
This issue discusses palliative care and hematopoietic cell transplant, examines anticoagulation in patients with obesity, and more.
